Product
KL003 cell injection Drug Product
1 clinical trial
1 indication
Indication
Beta-ThalassemiaClinical trial
Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia.Status: Recruiting, Estimated PCD: 2025-08-20